Chronic angiotensin receptor activation promotes hepatic triacylglycerol accumulation during an acute glucose challenge in obese-insulin-resistant OLETF rats

PURPOSE: Angiotensin receptor blockers (ARBs) can ameliorate metabolic syndrome (MetS)-associated dyslipidemia, hepatic steatosis, and glucose intolerance, suggesting that angiotensin receptor (AT1) over-activation contributes to impaired lipid and glucose metabolism, which is characteristic of MetS...

Descripción completa

Detalles Bibliográficos
Autores principales: Godoy-Lugo, Jose A., Thorwald, Max A., Hui, David Y., Nishiyama, Akira, Nakano, Daisuke, Soñanez-Organis, Jose G., Ortiz, Rudy M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8763929/
https://www.ncbi.nlm.nih.gov/pubmed/34327606
http://dx.doi.org/10.1007/s12020-021-02834-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8763929/
https://www.ncbi.nlm.nih.gov/pubmed/34327606
http://dx.doi.org/10.1007/s12020-021-02834-7

Ejemplares similares